MAPS Capital Management

MAPS Capital provides C level executive services for startups, foreign companies seeking US presence, international marketing and business development in addition to seed financing and assistance in venture capital funding. We specialize in Web 2.0 services, advertising analytics, medical diagnostics and technologies related to renewable energy such as magnetics, thermoelectrics and solar photovoltaics. We have extensive experience and applications knowledge in social media networks, behavioral targeting, monetization of web traffic, acquisition of users, viral programs for web startups and programming solutions based on the Open Social API platform. Our primary office is in San Francisco, California with offices in Silicon Valley, Hong Kong and San Diego.

Wang Jinyin

co-CEO

2 past transactions

Tongjia Hongrui Technology

Series C in 2025
Tongjia Hongrui Technology specializes in providing dry vacuum pump equipment and system technology services to the semiconductor sector.

Generate Biomedicines

Series C in 2023
Generate Biomedicines, Inc. is a biotechnology company based in Cambridge, Massachusetts, focused on developing innovative therapeutics through its pioneering platform in Generative Biology. Established in 2018, the company utilizes machine learning to analyze existing proteins, enabling it to understand the principles governing the relationship between genetic sequences and protein structure. This approach facilitates the invention of novel antibodies, peptides, enzymes, receptors, and other protein-based therapeutics optimized for specific biological functions. By harnessing its advanced technology, Generate Biomedicines aims to accelerate drug discovery by generating new biological molecules with significant therapeutic potential. Originally known as Generate Biologics, the company adopted its current name in March 2020 to reflect its expanded focus on biomedicine.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.